Topics

Tri-Source Pharma Company Profile

21:33 EDT 21st September 2019 | BioPortfolio

Established in 2016, Tri-Source Pharma was formed for capital investment and management oversight of its subsidiary companies. Its goal is to grow and synergize each of its companies’ ability to expand. Tri-Source has a network of over 60,000 veterinary hospitals and over 150,000 human healthcare providers nationwide, which substantiates its positioning for solid, domestic and global expansion into the Americas and European markets.


News Articles [1119 Associated News Articles listed on BioPortfolio]

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

The 2019 European Pharma Handbook – Covers All 28 EU Countries, and Norway, Russia, Serbia, Switzerland and Ukraine – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “European Pharma Handbook 2019” directory has been added to ResearchAndMarkets.com’s offering. The European Pharma Handbook provides pharmaceut...

Forward Pharma to Participate in the Fall Investor Summit in New York

COPENHAGEN, DENMARK / ACCESSWIRE / Sep. 5, 2019 / Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in the Fall ...

FSD Pharma forms new alliance for pharma-grade cannabinoids

Canada-based FSD Pharma has signed a non-binding letter of intent (LOI) with algae technology company Solarvest BioEnergy for the development...Read More... The post FSD Pharma forms new alliance for ...

EVER Pharma acquires Amneal Deutschland GmbH and extends its commercial presence in Europe

EVER Pharma Holding Ges.m.b.H (Austria) announced today that it has completed the acquisition of Amneal Deutschland GmbH, a subsidiary of Amneal Pharmaceuticals that operates the ...

FSD Pharma: Tenbagger oder Rohrkrepierer?

FSD Pharma ist das Mutterunternehmen der FC Pharma Inc, welche ein lizensierter Marihuana Hersteller aus Kanada ist. Das Unternehmen ist auf die Produktion von Cannabis für den medizinischen Gebrau.....

FSD Pharma Inc: The Best Under-the-Radar Cannabis Penny Stock

FSD Pharma Inc FSD Pharma Inc (OTCMKTS:FSDDF, CNSX:HUGE) is one of those cannabis companies that has been operating quietly in the background, getting everything it needs to become one of the large...

Why pharma engagement on twitter matters!

The fact that thousands of stakeholders chose to follow pharma accounts on twitter deserves our attention. It says that there are people out there genuinely interested in what pharma has ...

Drugs and Medications [83 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 0.5 mg

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 1 mg

Urea [mayne pharma inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [aventis pharma ltd.]

NA

Ribavirin [aurobindo pharma limited]

NA

PubMed Articles [462 Associated PubMed Articles listed on BioPortfolio]

Data science tools and applications on the way to Pharma 4.0.

Multiple obstacles are driving the digital transformation of the biopharmaceutical industry. Novel digital techniques, often marketed as 'Pharma 4.0', are thought to solve some long-existing obstacles...

The Art of Virtualizing Pharma R&D.

Physicians in the pharmaceutical industry: their roles, motivations, and perspectives.

Although physicians occupy a significant number of key positions in the pharmaceutical industry, practicing clinicians are often unaware of the variety of career paths within this industry, or of the ...

Establishing and Maintaining a Robust Sample Management System.

This paper has been written by the SLAS Sample Management Special Interest Group to serve as a guide to the best practices and methods in establishing and maintaining a high-quality sample management ...

Potential effects of increased openness in pharma: the original knowledge behind new drugs.

This study seeks to determine potential changes in the degree of openness in pharmaceutical R&D by investigating where the knowledge behind new molecular entities (NMEs) comes from in terms of type of...

Clinical Trials [847 Associated Clinical Trials listed on BioPortfolio]

Source Monitoring Déficit in Neuropsychiatric Population

the investigators will measure source-monitoring ability in patients with several neuropsychiatric condition and in healthy controls appaired in age, sex and educational level. Source-moni...

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Companies [1456 Associated Companies listed on BioPortfolio]

Tri-Source Pharma

Established in 2016, Tri-Source Pharma was formed for capital investment and management oversight of its subsidiary companies. Its goal is to grow and synergize each of its compan...

Prophylix Pharma AS

Prophylix Pharma AS coordinate the PROFNAIT consortium’s drug development activities and lead the procurement of specialty source plasma in the US and manufacture of NAITgam....

Tanner Pharma Group

For over 15 years, Tanner Pharma Group has provided highly specialized pharmaceutical services to its partners around the world. Leading pharmaceutical and biotech companies partn...

Wolters Kluwer Pharma Solutions, Inc.

Wolters Kluwer Pharma Solutions, Inc. (Bridgewater, NJ) is a leading provider of information and analytics to the pharmaceutical, biotech, and medical device industries. The company's brands include A...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

More Information about "Tri-Source Pharma" on BioPortfolio

We have published hundreds of Tri-Source Pharma news stories on BioPortfolio along with dozens of Tri-Source Pharma Clinical Trials and PubMed Articles about Tri-Source Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tri-Source Pharma Companies in our database. You can also find out about relevant Tri-Source Pharma Drugs and Medications on this site too.

Quick Search

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record